About Us - Vivodyne
Andrew brings over two decades of expertise pioneering R&D in the semiconductor, biotechnology and MEMS industries. At Vivodyne, Andrew spearheads the development and implementation of cutting-edge robotic technology crucial for advancing human organ tissue production for drug discovery.
Andrei Georgescu, Ph.D. - Vivodyne | LinkedIn
View Andrei Georgescu, Ph.D.’s profile on LinkedIn, a professional community of 1 billion members. Experience: Vivodyne · Education: University of Pennsylvania · Location: Philadelphia · 500 ...
- 500+ connections
- Location: Vivodyne
This Startup Raised $38 Million To Fill One Of The Biggest ... - Forbes
Nov 22, 2023 · “These AI models are not creating drugs that are substantially better than human designed drugs,” Andrei Georgescu, CEO of Vivodyne told Forbes. That’s because, he explains, there’s simply not...
Andrei Georgescu - Wikipedia
Andrei Georgescu (born 12 March 1983 in Bucharest, Romania) is a Romanian coach for the best team in Romania, Dinamo Bucharest
Vivodyne's Lab Grown Human Tissue Platform Gets Real with $38 …
Nov 22, 2023 · Andrei Georgescu, PhD, CEO of Vivodyne, was hoping to couple his interests in science and engineering when he chose UPenn for his graduate research.
Andrei Georgescu Profiles - Facebook
View the profiles of people named Andrei Georgescu. Join Facebook to connect with Andrei Georgescu and others you may know. Facebook gives people the...
Andrei Georgescu
A biotech startup that’s changing how scientists study human biology & develop therapeutics. Vivodyne’s platform technology creates a new preclinical drug development pipeline that starts and ends in lab-grown human tissues.
Bioengineering’s Organ-on-a-chip Spin-off is Growing
May 3, 2021 · Andrei Georgescu (left) and Dan Huh are the co-founders of Vivodyne, a spin-off of Huh’s BIOLines lab. Dan Huh, Associate Professor in the Department of Bioengineering, has been steadily growing a collection of organs-on-chips.
Andrei Georgescu - BIO Investor Forum 2024
Oct 16, 2024 · Dr. Andrei Georgescu spearheads Vivodyne’s vision of reshaping therapeutics development. The loss of translation between animal studies and human trials compelled him to co-found Vivodyne in 2020 and create an entirely new platform from the ground up.
Better Therapeutics Using Lab-Grown Tissue with Andrei Georgescu …
Aug 26, 2024 · Today, I am joined by Dr. Andrei Georgescu, Founder and CEO of Vivodyne, a groundbreaking biotechnology company that is transforming how scientists study human biology and develop new therapeutics. In this episode, he reveals how Vivodyne harnesses lab-grown tissue and advanced multimodal AI to create more effective therapeutics.